The weekend before last saw the Poonawallas celebrating the navjote ceremony of Cyrus and Darius, the children of Adar and Natasha Poonawalla, the family which brings great pride not just to our community and the nation, but to the world, being the founders of Serum Institute of India (SII), established by Dr. Cyrus Poonawalla in…
On 4th April, 2022, Adar Poonawalla, the CEO of Serum Institute of India (SII), the world’s largest producer of vaccines by volumes and the leading provider of the anti-Covid vaccine, Covishield, said that India’s current low number of active coronavirus cases could be attributed to the fact that it opted for the right vaccine for…
Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. He also thanked the government for all the support provided to Serum Institute and…
₹ 600 For Pvt / ₹ 400 For State Govts. On 21st April, 2021, Adar Poonawalla, CEO of the Pune-based Serum Institue of India (SII), the world’s largest producer of vaccines, released a media statement, where the price for the Covishield vaccine was fixed at ₹600 per dose for private hospitals and ₹400 per jab for State…
Adar Poonawalla, the CEO of the world’s largest vaccine manufacturer by volumes – the Serum Institute of India (SII), was recently named as one among six people cited as ‘Asians Of The Year’, by Singapore’s leading daily, The Straits Times, for their work in fighting the COVID-19 pandemic. The Straits Times’ ‘Asians of the Year’…
On 26th November, 2020, the Prime Minister Office (PMO) confirmed that Prime Minister Shri Narendra Modi, would be visiting the Serum Institute of India (SII) in Pune’s Hadapsar area today, on 28th November, 2020. Scheduled to arrive around 1:00 pm and leave around 2:30 pm (as per the tentative schedule), PM Modi is likely to…
As per the latest news reports, Adar Poonawalla, CEO of the world’s largest vaccine manufacturer – Serum Institute of India (SII), shared that the Oxford Coronavirus Vaccine, whose results of Phase I, II trials have appeared safe, will be called ‘Covishield’ in India. He said that SII has sought an official approval from the Drug…
Adar Poonawalla – the son of the community’s leading tycoon and one of the foremost names in the Indian and global pharma industry – the founder of Serum Institute of India, Cyrus Poonawalla – made his debut investment in India’s Food Service Sector. Adar has acquired a stake in a specialty coffee in biscuits, founded…